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A report on the conference ‘Epigenetics and the dynamic
genome’, 30 June-2 July 2005, Babraham, Cambridge, UK. 
For a cell to remember its identity and its goal in life takes
more than genetic information in the form of DNA. On and
off states of genes have to be preserved, sometimes over gen-
erations. This is done by a set of mechanisms that are often
called epigenetic, as they are not encoded by the genome. A
meeting on ‘Epigenetics and the dynamic genome’ at the
Babraham Institute in the countryside outside Cambridge
was an opportunity to hear the latest progress in this fast-
moving field. 
New players in epigenetic regulation 
Understanding the full spectrum of histone modifications
and their effects on gene regulation is central to understand-
ing epigenetics. Tony Kouzarides (University of Cambridge,
UK) opened the meeting by revealing a new histone-modify-
ing enzyme in budding yeast. The yeast protein Fpr4 can iso-
merize proline 38 in histone H3, which has the effect of
inhibiting the methylation of lysine 36 on histone H3 (H3
K36). Yang Shi (Harvard Medical School, Boston, USA)
updated us on lysine-specific histone demethylase 1 (LSD1),
a histone H3 K4 demethylase. He reported that the cofactor
for the repressor element 1 silencing transcription factor
(coREST) binds LSD1 and is essential for its activity on
nucleosomes. Genevieve Almouzni (Curie Institute, Paris,
France) showed that the protein kinase complex Dbf4/Cdc7
phosphorylates the histone chaperone chromatin-assembly
factor 1 (CAF1) during the early S phase of the cell cycle.
Phosphorylation by Dbf4/Cdc7 stabilizes CAF1 in its
monomeric form. This form binds proliferating cell nuclear
antigen (PCNA), the replication sliding clamp, thus facilitating
the role of CAF1 in replication-dependent chromatin
assembly. Regulating CAF1 function is a novel way for the
‘not so famous cell cycle kinase’ Dbf4/Cdc7 to ensure a tem-
poral coordination between DNA replication and nucleo-
some assembly.
Modifications to DNA itself are also crucial to epigenetic reg-
ulation. Researchers have been mystified by the molecular
mechanisms responsible for the waves of rapid DNA
demethylation that are essential for the early development of
many species. Recently, various classes of DNA-modifying
enzymes have started to emerge that could be responsible for
this phenomenon. Primo Schär (University of Basel, Switzer-
land) showed that thymidine DNA glycosylase (TDG), unlike
most DNA glycosylases, is essential for embryonic develop-
ment. TDG removes the pyrimidines from G:T or G:U mis-
matches that occur by deamination of cytosine or 5-methyl
cytosine, respectively. This potentially makes TDG part of a
5-methyl cytosine disassembly line, downstream of enzymes
such as activation-induced cytidine deaminase (AID) that
was reported by Svend Petersen-Mahrt (Cancer Research
UK, Clare Hall Laboratories, South Mimms, UK) as being
implicated in pluripotency in mammals. Schär showed that
TDG-knockout cells have phenotypes implicating TDG not
only in DNA repair but also in the transcriptional regulation
of gene expression.
Genomic regulation by histone modification or
histone replacement
One of the aims of epigenetics research is to determine the
components that carry cellular ‘memory’ from cell generation
to generation. Bryan Turner (University of Birmingham, UK)
argued that as metaphase chromosomes are the inheritedentity during cell division, they are presumably the main
source of  somatic cellular memory. Using immunofluores-
cence studies on metaphase chromosomes, he showed that
histone H3 isoforms mono-, di- and trimethylated at K4 show
differing and characteristic distribution patterns. On the
human X chromosome, these marks define a region rich in
genes that escape X inactivation. Robert Feil (Institute of
Molecular Genetics, Montpellier, France) showed that the H3
K9 methyltransferase G9A is essential for placenta-specific
imprinting in the mouse. This fits well with his group’s previ-
ous work that showed that histone modifications are associ-
ated with the maintenance of placental imprinting, whereas
embryonic imprinting is dependent on DNA methylation. 
As well as covalent modifications to histones and DNA, the
behavior of chromatin can be modified by the replacement of
the canonical histones with variant histones. Steve Henikoff
(Fred Hutchinson Cancer Center, Seattle, USA) used chro-
matin-affinity purification of histone variant H3.3 in combi-
nation with tiling microarrays to determine the areas in the
Drosophila genome that are enriched in this replacement
histone, and compared the resulting profiles to published
chromatin immunoprecipitation (ChIP) datasets for histone
H3 dimethyl K4 and RNA polymerase II. In line with the
presumed role for H3.3 in marking transcribed DNA, H3.3
abundance overlaps strongly with areas enriched in H3
dimethyl K4 and RNA polymerase II. Interestingly, H3.3 was
enriched both upstream and downstream of transcription
units, except for a strong dip in abundance over promoters
that is attributable to nucleosome depletion over active pro-
moters. Alain Verreault (Université de Montréal, Canada)
presented an elegant study of a novel histone modification,
H3 K56 acetylation, and its role in the repair of double-
strand breaks in DNA. K56 is located at the DNA entry/exit
point in the nucleosome and is in an acetylated state when
histone H3 is deposited during S phase but is deacetylated
thereafter. K56 acetylation persists near double-strand
breaks until repair has occurred, however, suggesting a
marking function. Indeed, a K56 to arginine substitution
makes yeast very sensitive to agents such as bleomycin or
camptothecin that induce double-strand breaks. 
Genome reprogramming
The power of the environment over DNA is perhaps most
evident in experiments where the identity of a cell or a
nucleus dramatically changes as a result of alterations in the
composition of the nucleoplasm. One of the classical systems
for studying nuclear reprogramming has been nuclear trans-
fer in Xenopus. An inspiring and thought-provoking talk by
John Gurdon (University of Cambridge, UK), one of the pio-
neers in this field, started off a session on this topic. He
showed that nuclei from both neuroectoderm and endoderm
cells, taken from opposite sides of a blastula-stage embryo,
can be efficiently reprogrammed (in 30% of cells) when
transplanted into an enucleated Xenopus egg, yielding viable
tadpoles. Analysis of lineage markers revealed, however, that
50-80% of the blastulae derived from these transplanted
nuclei still express markers from the original program of
their donor nuclei. This poses several questions. Are the
markers evidence of a failure to completely erase the previ-
ous program, and if so, why does that not disrupt normal
development? Is incomplete reprogramming the reason for
the very low efficiency of cloning in mammals, and is coping
better with aberrant gene expression the key to the much
greater success of cloning in amphibians? 
Rudolf Jaenisch (Whitehead Institute, Cambridge, USA)
reported on the gene targets of the key transcription factors
Oct4, Nanog and Sox2 in maintaining pluripotency in mam-
malian embryonic stem (ES) cells. ChIP data show that these
factors share about 20% of their respective sets of target
genes, including many Hox genes. Genes bound by all three
factors can be active or repressed. Jaenisch suggested that
an autoregulatory feedback loop between the Oct4, Nanog
and Sox2 genes and their products is important for main-
taining pluripotency.
Over the past few years Austin Smith (University of Edin-
burgh, UK) has expanded our knowledge of the different
signals that are important for maintaining cultured mouse
ES cells in an undifferentiated state, or for forcing their dif-
ferentiation. This has resulted in several protocols for con-
trolled, quantitative differentiation of ES cells. He reported
on his latest experiment, the derivation of neural stem cells
from ES cells. ES cells can be differentiated into Sox1-
expressing neural precursors. By addition of fibroblast
growth factor and epidermal growth factor these precursors
can be expanded into neural stem cells that no longer
express Sox1 and that can be propagated indefinitely without
losing their potential to differentiate into neurons, astrocytes
or oligodendrocytes. They can also be transferred into a
mouse brain, where they contribute to the appropriate lin-
eages without causing tumors. 
Chromosome dynamics
A paradigm for the regulation of gene expression on a chro-
mosome-wide level is X-chromosome inactivation in female
mammals. X inactivation is triggered by a noncoding RNA
called Xist that spreads along the entire length of the X chro-
mosome. Neil Brockdorff (MRC Clinical Sciences Centre,
London, UK) addressed one question about the inactive X:
how can repression from an initial point spread and be
maintained chromosome-wide? To investigate this he is
looking at X-autosome translocations, in which the spread-
ing of X inactivation beyond the X-autosome breakpoint is
often limited. Previous data suggested that repression can
spread into the autosome but is not efficiently maintained
through subsequent development, the so-called ‘spread-and-
retreat’ model. Brockdorff’s data provide an example of a dif-
ferent mechanism occurring in a specific X;autosome
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sequences resist the initial spreading of Xist RNA, and there-
fore of the inactivation signal. He discussed a hypothesis,
first proposed by Mary Lyon a few years ago, that repression
may occur more efficiently on the X chromosome as a result
of its high density of LINE repeats. Interestingly, a large
region of the autosome around the translocation breakpoint
is depleted in LINE repeats, providing a possible explanation
for the block in Xist RNA spreading. Phil Avner (Pasteur
Institute, Paris, France) showed that in trophoblast stem
cells the inactive X chromosome can switch into the active X,
albeit at a low (10-5) frequency. Using selection for activation
of a marker on the inactive X, he reported that such cells are
less stable in maintaining their X inactivation than are
extraembryonic endoderm cells.
Recent years have seen a revolution in the understanding of
the three-dimensional location of active or repressed genes
in the nucleus, as a result of new chromosome conformation
capture (3C) techniques or the optimization of older ones
such as fluorescence in situ hybridization (FISH). Using
three-dimensional FISH, Cameron Osborne (Babraham
Institute, Cambridge, UK) showed that in the B cells of the
immune system the c-myc gene is recruited to an RNA poly-
merase II focus upon transcriptional induction. The c-myc
gene co-localizes in such foci with active immunoglobulin
genes such as IgH, Ig and Ig, which are all situated on dif-
ferent chromosomes. Interestingly, the frequency of co-
localization of c-myc  and the different immunoglobulin
genes correlates well with the frequency of different c-myc-
immunoglobulin translocations, which cause lymphomas.
Heidi Sutherland (MRC Human Genetics Unit, Edinburgh,
UK) reported on the nuclear localization of ZFP647, a
member of the family of Krüppel-associated box (KRAB)
zinc finger proteins (ZFP) that has several hundred members
in mammals but only one known in chicken and Xenopus.
Transcriptional repression by KRAB proteins acts via KRAB-
associated protein 1 (KAP1), which binds heterochromatin
protein 1 (HP1). Sutherland showed that ZFP647 co-localizes
with KAP1, HP1 and HP1 in nuclear foci upon differentia-
tion of ES cells. Another KRAB protein, NT2, has a similar
localization pattern. This may suggest that KRAB proteins
repress genes by recruiting them to foci that may act as
silencing factories. 
Daniel Mertens (German Cancer Research Center, Heidel-
berg, Germany) investigates human cancer-associated
genomic regions that show deletion of one allele without the
other being mutated. He has found an example where,
within tumor tissue, the genes in the non-mutated alleles are
always silenced and late replicating. Silencing is not corre-
lated with the paternal or maternal origin of the allele. Inter-
estingly, treatment with the histone deacetylase inhibitor
trichostatin A (TSA) or the DNA methylation inhibitor 5-aza-
cytidine reactivated expression of the silent allele but did not
affect the late replication timing. Dirk Schübeler (Friedrich
Miescher Institute, Basel, Switzerland) presented the results
of DNA immunoprecipitation with an anti-5-methylcytidine
antibody and subsequent microarray analysis, covering the
complete human genome as bacterial artifical chromosome
(BAC) clones. Comparing the active and inactive X chromo-
some, he suggested that the inactive X is hypermethylated
only in gene-rich regions but, unexpectedly, relatively
hypomethylated in gene-poor regions. Also, gene-rich
regions on autosomal chromosomes are more highly methy-
lated than gene-poor regions, possibly to prevent aberrant
gene transcription. 
Rob Martienssen (Cold Spring Harbor Laboratory, New
York, USA) wound up the meeting by updating us on the
very fast-moving field of heterochromatin formation by RNA
interference (RNAi). He showed that both transcription by
RNA polymerase II (Pol II) and the mRNA-processing
machinery are involved in RNAi-mediated silencing in the
fission yeast Schizosaccharomyces pombe. A point mutation
in the RNA Pol II subunit RPB2 abolishes the generation of
small interfering RNAs (siRNAs) from centromeric tran-
scripts. Deletion of Rik1, a subunit of the poly(A) polymerase
complex, also leads to a loss of siRNA processing and loss of
histone H3 K9 methylation. This fits well with the known
recruitment by Rik1 of Clr4, the S. pombe H3 K9 methylase.
Nature has devised many complex and interlinked mecha-
nisms to generate and maintain multiple cell types using the
same genetic material. As it becomes increasingly clear that
many diseases are due to defects that are not genetically
encoded, understanding these mechanisms and to what
extent they apply to disease is of utmost importance. Also,
using these epigenetic mechanisms - RNA interference, for
example - may sometimes be the only way to cure disease, as
genetic manipulation is not always conceivable. This
meeting succeeded in bringing together scientists from dif-
ferent disciplines in an attempt to forward our wider under-
standing of epigenetic phenomena, and it deserves a regular
follow-up.
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